Literature DB >> 15970469

Infection and inflammation in cystic fibrosis: a short review.

Harry Heijerman1.   

Abstract

In most patients with cystic fibrosis (CF) life expectancy is limited due to a progressive loss of functional lung tissue. Already very early in life a persistent neutrophylic inflammation can be demonstrated in the airways. The cause of this inflammation, the role of CFTR and different CF specific bacteria like Pseudomonas aeruginosa are not well understood. This short review summarises the current understanding and hypothesis of the origin of this complicated process of inflammation and infection. Better understanding of this process may lead to the development of new treatment modalities of CF lung disease and consequent improvement of life expectancy.

Entities:  

Mesh:

Year:  2005        PMID: 15970469     DOI: 10.1016/j.jcf.2005.05.005

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  54 in total

1.  Elevated inflammatory response in caveolin-1-deficient mice with Pseudomonas aeruginosa infection is mediated by STAT3 protein and nuclear factor kappaB (NF-kappaB).

Authors:  Kefei Yuan; Canhua Huang; John Fox; Madeleine Gaid; Andrew Weaver; Guoping Li; Brij B Singh; Hongwei Gao; Min Wu
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms.

Authors:  Rinki Kapoor; Mayken W Wadman; Michelle T Dohm; Ann M Czyzewski; Alfred M Spormann; Annelise E Barron
Journal:  Antimicrob Agents Chemother       Date:  2011-03-21       Impact factor: 5.191

3.  Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa.

Authors:  Clement Mugabe; Majed Halwani; Ali O Azghani; Robert M Lafrenie; Abdelwahab Omri
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.

Authors:  Vibeke B Rudkjøbing; Trine R Thomsen; Morten Alhede; Kasper N Kragh; Per H Nielsen; Ulla R Johansen; Michael Givskov; Niels Høiby; Thomas Bjarnsholt
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

5.  Comparing the microbiota of the cystic fibrosis lung and human gut.

Authors:  Geraint B Rogers; Mary P Carroll; Lucas R Hoffman; Alan W Walker; David A Fine; Kenneth D Bruce
Journal:  Gut Microbes       Date:  2010-01-29

6.  Airway epithelial homeostasis and planar cell polarity signaling depend on multiciliated cell differentiation.

Authors:  Eszter K Vladar; Jayakar V Nayak; Carlos E Milla; Jeffrey D Axelrod
Journal:  JCI Insight       Date:  2016-08-18

7.  In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.

Authors:  Qianru Yu; Edward F Griffin; Sophie Moreau-Marquis; Joseph D Schwartzman; Bruce A Stanton; George A O'Toole
Journal:  J Antimicrob Chemother       Date:  2012-07-26       Impact factor: 5.790

8.  Adult onset lung disease following transient disruption of fetal stretch-induced differentiation.

Authors:  Joseph J Hudak; Erin Killeen; Ashok Chandran; J Craig Cohen; Janet E Larson
Journal:  Respir Res       Date:  2009-05-06

9.  The calpain, caspase 12, caspase 3 cascade leading to apoptosis is altered in F508del-CFTR expressing cells.

Authors:  Mathieu Kerbiriou; Ling Teng; Nathalie Benz; Pascal Trouvé; Claude Férec
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  Inhibition of NFkappaB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation.

Authors:  Rangan Maitra; Melissa A Porter; Shan Huang; Brian P Gilmour
Journal:  J Inflamm (Lond)       Date:  2009-05-13       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.